Leonard H. Calabrese, DO - Mapping the Path to Better Patient Outcomes in Rheumatoid Arthritis and Psoriatic Arthritis: Need-to-Know Information and Practical Guidance About JAK Inhibitors for Advanced Practice Providers - a podcast by PVI, PeerView Institute for Medical Education
from 2020-09-28T18:00
Go online to PeerView.com/ZHN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatic diseases discusses strategies to select and optimize treatment for individual patients with RA and PsA, focusing on the appropriate clinical utilization of newer treatment options (ie, JAK inhibitors). Upon completion of this activity, participants will be able to: Outline advances that have improved the quality of care in rheumatic diseases, Explain the role of the JAK/STAT signaling pathway in the pathophysiology of RA and PsA, Summarize efficacy and safety data related to current JAK inhibitors for the treatment of RA and PsA, Treat RA and PsA in accordance with current evidence and guidelines, recognizing the role of non-anti-TNF therapies in patients with active disease, Incorporate JAK inhibitors into treatment plans for individual patients with RA or PsA, recognizing the importance of achieving therapeutic targets and a patient-centered approach to care.
Further episodes of PeerView Immunology
Further podcasts by PVI, PeerView Institute for Medical Education